ANIMAL HEALTH NEWS-October

This newsletter highlights several developments in the animal health industry, including Xeptiva Therapeutics raising $2.5 million for vaccine development, Virbac launching new joint supplements for cats, and FDA approvals for products like MoxiSolv Injection and Zenrelia. It also mentions key events such as Elanco's participation in the Global Sustainable Beef Conference, MSD Animal Health's donation of rabies vaccines, and new leadership roles at Royal Canin and Merck Animal Health expanding its vaccine platform. These updates showcase ongoing innovation and expansion in the sector. #animalhealth #market #newsletter #latinamerica #regulatoryaffairs #launches #results #sales #products

?? URUGUAY Xeptiva Therapeutics, a biotech startup that develops vaccines to alleviate chronic pain in animals, announced the close of its seed funding round, raising $2.5 million from international investors. The Uruguayan biotech company Xeptiva Therapeutics closed a $2.5 million seed round. This milestone included investment from three Uruguayan investment funds and three foreign ones. It was led by Zentynel Frontier Investments, specializing in the biotech sector, with the participation of iThink VC, ND Latam, dLocal co-founder Sergio Fogel, FEN Ventures, and Uruguay Biotech Ventures. Currently, the company is focused on developing vaccines to treat the two most prevalent chronic inflammatory diseases in companion animals: one for chronic pain due to osteoarthritis and another for atopic dermatitis, both in the clinical trial phase. (entnerd.com ).

?? Virbac launched Movoflex Soft Chews for cats, the next generation of joint health supplements. Movoflex Soft Chews for cats, the next generation of joint health supplements, is now also available for felines. With this launch, the company completes its range of joint supplements alongside the Movoflex Soft Chews S, M, L references for dogs. It contains a unique and complete formula of synergistic high-quality ingredients that support joint health and mobility in cats of all ages. Each ingredient has been selected for its own and synergistic benefits. This unique combination allows these joint supplements to start acting faster than other similar products. (animalshealth.es , Oct 2nd).

?? The FDA approved MoxiSolv Injection (moxidectin) — For the treatment and control of internal and external parasites in non-lactating dairy cattle. From Bimeda Animal Health Ltd. (dairyherd.com , Oct.)

?? Norbrook Inc. present at the Southwest Veterinary Symposium in Texas. The US-based subsidiary participated in this event with the team, as it is an excellent opportunity for animal health professionals to listen to over 100 speakers, network with industry experts, and continue their ongoing education. (Company Linkedin, October)

?? Royal Canin has a new member leading its finances in Brazil. Felipe Barrossi assumes the role of CFO amid an expansion scenario and new opportunities in the pet sector. Barrossi joined Mars Petcare in 2014 as Financial Planning Manager at Royal Canin Brazil (Photo: press release). He moved to France in 2018, where Royal Canin's headquarters are based, working as Global Financial Planning Manager until 2022 when he led the financial division of the Latam Seeds core in Bogotá. This year, Barrossi returns to Brazil to lead the financial operations of Royal Canin in the country. (caesegatos.com.br , Oct.)

?? Pet’s Best Life and Seraphina Therapeutics announced the launch of Longevity15 powered by fatty15 with pentadecanoic acid, designed to slow the biological mechanisms of aging and help protect cells while enhancing a dog's quality of life. (Vet Advantage)

?? Zoetis and Danone announced a joint business development plan enabling Danone to leverage Zoetis' genetic technologies globally, integrating sustainable practices into dairy genetics and selection. (company press release)

?? Elanco Animal Health Brazil participates in the Global Conference on Sustainable Beef 2024. Fernanda Hoe, General Director of Elanco Brazil and the first woman to lead an animal health industry in the country, will close the conference's agenda on October 2nd. The event takes place in Uruguay, from September 30 to October 4, bringing together players from the beef production chain and leaders from five continents. (itaqueraemnoticias.com.br , Oct.)

?? Elanco announces FDA approval and the launch of Zenrelia, offering an effective and safe solution in canine dermatology. In a comparative study, Zenrelia proved to be at least as effective as the market's usual JAK inhibitor on the primary endpoint, with an additional endpoint where Zenrelia achieved clinical remission of itch in 77% of dogs, compared to 53% of dogs treated with Apoquel (oclacitinib tablet). Zenrelia is a once-daily, safe, highly effective, and convenient oral JAK inhibitor for controlling itch associated with allergic dermatitis and controlling atopic dermatitis in dogs aged at least 12 months. (pmfarma.com , Sept.)

?? MSD Animal Health receives marketing authorization in Europe for Porcilis PCV M Hyo ID. The new vaccine protects against two of the most common pig diseases and, at the same time, offers efficient and animal-friendly administration through IDAL device technology. It offers protection against two of the most common pig pathogens: Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo). The vaccine will be available on the market in the first quarter of 2025. (pmfarma.com , October 1st)

?? MSD Animal Health Spain donates over 6 million rabies vaccines as part of its commitment to the elimination of zoonosis. Through the Ayfa Program, the company has donated over six million of its Nobivac rabies vaccines. The global philanthropic program is committed to helping achieve the World Health Organization's goal of zero human deaths from dog-transmitted rabies by 2030. In partnership with Mission Rabies and Rabies Free Africa, MSD Animal Health is celebrating this milestone and a 25-year commitment to eliminating rabies, calling for individuals, organizations, and governments to unite their efforts in the fight against rabies. (animalshealth.es , Oct.)

?? Merck Animal Health announced the expansion of the newly USDA-approved Nobivac NXT vaccine platform to include a feline leukemia virus (FeLV) vaccine. The vaccine is expected to be available at veterinary clinics and hospitals nationwide this fall. (businesswire)

?? The FDA announced it has approved Felix Pharmaceuticals Pvt. Ltd's generic Carprofen Soft Chewable Tablets. (FDA)

?? Ceva Animal Health Argentina presented innovative solutions in poultry health. Buenos Aires and Entre Ríos were chosen by Ceva Animal Health to introduce the new vaccines against Inclusion Body Hepatitis (IBH). Timea Tatar-Kis, Director of Ceva's Research and Scientific Support Unit, presented the findings of studies on the new Cevac? IBH Multi K vaccine, designed to combat the main avian adenovirus serotypes that cause inclusion body hepatitis. Tatar-Kis provided details about the efficacy trials and the vaccine's potential to protect birds from their first day of life. (motivar.com.ar , Sept. 29th)

?? The FDA announced it has approved Cronus Pharma Specialities India Private Ltd.'s Tulaject 25 and Tulaject 100 (generic tulathromycin) for swine and calves. (FDA)

?? Holliday Scott Argentina celebrates 60 years with product innovation, investments in its Zarate plant, and a new branch in Brazil. Although a strong company in the local Argentine market, the company founded by Nelson Mora is expanding globally. They are present in the three Americas, some European countries, as well as in the Middle East. In the medium term, the challenge is to continue seizing opportunities in various markets, increasing their market share in countries like Mexico and Brazil, as well as in the Middle East and Southeast Asia. (motivar.com.ar , October)

?? Zomedica Corp. announced expanding its European distribution partnership with Grovet, an equine-focused veterinary distributor. The updated agreement offers Grovet exclusive equine distribution rights for Zomedica’s equine PulseVet and TRUFORMA product platforms in 27 EU countries, and on a non-exclusive basis in Italy and the UK. (biospace.com )

BERNARDO OTERO Leadership in ANIMAL HEALTH

CEO & Founder of NEXUS ANIMAL HEALTH

Please, ?? Subscribe on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321